Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Angelica Sette
Introduction
Angelica Sette is a prominent inventor based in Cambridge, GB. She has made significant strides in the field of therapeutic molecules, particularly in the development of agents that target LAG-3 and PD-1. Her work is crucial in advancing treatments for various diseases.
Latest Patents
Angelica holds a patent for therapeutic molecules that bind to LAG3 and PD1. This invention focuses on LAG-3 binding agents, specifically variable heavy chain (V) sdAbs and bispecific agents that target both LAG-3 and PD-1. The application of these binding agents is aimed at the treatment, prevention, and detection of diseases.
Career Highlights
Throughout her career, Angelica has demonstrated a commitment to innovation in biotechnology. Her work at Crescendo Biologics Limited has positioned her as a key player in the development of novel therapeutic strategies.
Collaborations
Angelica collaborates with talented individuals such as Carolyn Edwards and Isabelle Osuch, contributing to a dynamic research environment that fosters innovation.
Conclusion
Angelica Sette's contributions to the field of therapeutic molecules exemplify her dedication to advancing medical science. Her innovative work continues to pave the way for new treatment options and highlights the importance of collaboration in research.